{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:09:53Z","timestamp":1782738593428,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11060-025-05121-x","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:45:25Z","timestamp":1750311925000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases"],"prefix":"10.1007","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9362-7766","authenticated-orcid":false,"given":"Kylie","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Das","family":"Sivadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Plumridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Spain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9056-0903","authenticated-orcid":false,"given":"Joseph","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"4","key":"5121_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/01.nrl.0000080951.78533.c4","volume":"9","author":"P Giglio","year":"2003","unstructured":"Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurologist 9(4):180\u2013188. https:\/\/doi.org\/10.1097\/01.nrl.0000080951.78533.c4","journal-title":"Neurologist"},{"issue":"7","key":"5121_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11864-021-00854-z","volume":"22","author":"BA Vellayappan","year":"2021","unstructured":"Vellayappan BA, McGranahan T, Graber J, Taylor L, Venur V, Ellenbogen R, Sloan AE, Redmond KJ, Foote M, Chao ST, Suh JH, Chang EL, Sahgal A, Lo SS (2021) Radiation necrosis from stereotactic Radiosurgery-How do we mitigate?? Curr Treat Options Oncol 22(7):57. https:\/\/doi.org\/10.1007\/s11864-021-00854-z","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"5121_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11060-011-0713-3","volume":"106","author":"R Ryan","year":"2012","unstructured":"Ryan R, Booth S, Price S (2012) Corticosteroid-use in primary and secondary brain tumour patients: a review. J Neurooncol 106(3):449\u2013459. https:\/\/doi.org\/10.1007\/s11060-011-0713-3","journal-title":"J Neurooncol"},{"issue":"4","key":"5121_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00520-001-0333-0","volume":"10","author":"C Hempen","year":"2002","unstructured":"Hempen C, Weiss E, Hess CF (2002) Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects? Support Care Cancer 10(4):322\u2013328. https:\/\/doi.org\/10.1007\/s00520-001-0333-0","journal-title":"Support Care Cancer"},{"issue":"8","key":"5121_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/neuonc\/noab046","volume":"23","author":"CAC Jessurun","year":"2021","unstructured":"Jessurun CAC, Hulsbergen AFC, de Wit AE, Tewarie IA, Snijders TJ, Verhoeff JJC, Phillips JG, Reardon DA, Mekary RA, Broekman MLD (2021) The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis. Neuro Oncol 23(8):1261\u20131272. https:\/\/doi.org\/10.1093\/neuonc\/noab046","journal-title":"Neuro Oncol"},{"issue":"8","key":"5121_CR6","first-page":"3348","volume":"61","author":"YQ Li","year":"2001","unstructured":"Li YQ, Ballinger JR, Nordal RA, Su ZF, Wong CS (2001) Hypoxia in radiation-induced blood-spinal cord barrier breakdown. Cancer Res 61(8):3348\u20133354","journal-title":"Cancer Res"},{"issue":"2","key":"5121_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323\u2013326. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.10.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5121_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","volume":"18","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Shi S, Yuan Z, Chang JY (2019) Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues. Mol Cancer 18(1):21. https:\/\/doi.org\/10.1186\/s12943-019-0950-1","journal-title":"Mol Cancer"},{"key":"5121_CR9","doi-asserted-by":"publisher","first-page":"593449","DOI":"10.3389\/fonc.2021.593449","volume":"11","author":"G Liao","year":"2021","unstructured":"Liao G, Khan M, Zhao Z, Arooj S, Yan M, Li X (2021) Bevacizumab treatment of Radiation-Induced brain necrosis: A systematic review. Front Oncol 11:593449. https:\/\/doi.org\/10.3389\/fonc.2021.593449","journal-title":"Front Oncol"},{"issue":"5","key":"5121_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3340\/jkns.2022.0229","volume":"66","author":"SH Lee","year":"2023","unstructured":"Lee SH, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI (2023) Effect of bevacizumab treatment in cerebral radiation necrosis: investigation of response predictors in a Single-Center experience. J Korean Neurosurg Soc 66(5):562\u2013572. https:\/\/doi.org\/10.3340\/jkns.2022.0229","journal-title":"J Korean Neurosurg Soc"},{"issue":"3","key":"5121_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/1754-9485.13847","volume":"69","author":"A Lasocki","year":"2025","unstructured":"Lasocki A, Sia J, Stuckey SL (2025) Differentiation between radiation necrosis and true tumour progression after radiotherapy to intracranial metastases. J Med Imaging Radiat Oncol 69(3):414\u2013424. https:\/\/doi.org\/10.1111\/1754-9485.13847","journal-title":"J Med Imaging Radiat Oncol"},{"key":"5121_CR10","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.2147\/ott.S223258","volume":"12","author":"H Zhuang","year":"2019","unstructured":"Zhuang H, Zhuang H, Shi S, Wang Y (2019) Ultra-Low-Dose bevacizumab for cerebral radiation necrosis: A prospective phase II clinical study. Onco Targets Ther 12:8447\u20138453. https:\/\/doi.org\/10.2147\/ott.S223258","journal-title":"Onco Targets Ther"},{"issue":"1","key":"5121_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-021-07889-3","volume":"21","author":"M Khan","year":"2021","unstructured":"Khan M, Zhao Z, Arooj S, Liao G (2021) Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis. BMC Cancer 21(1):167. https:\/\/doi.org\/10.1186\/s12885-021-07889-3","journal-title":"BMC Cancer"},{"key":"5121_CR23","doi-asserted-by":"publisher","first-page":"100600","DOI":"10.1016\/j.ctro.2023.100600","volume":"39","author":"E Meixner","year":"2023","unstructured":"Meixner E, H\u00f6rner-Rieber J, Lischalk JW, Eichkorn T, Kr\u00e4mer A, Sandrini E, Paul A, Hoegen P, Deng M, Welzel T, Erdem S, Debus J, K\u00f6nig L (2023) Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: clinical and radiological impact of bevacizumab and corticosteroids. Clin Transl Radiat Oncol 39:100600. https:\/\/doi.org\/10.1016\/j.ctro.2023.100600","journal-title":"Clin Transl Radiat Oncol"},{"issue":"30","key":"5121_CR34","doi-asserted-by":"publisher","first-page":"48842","DOI":"10.18632\/oncotarget.7768","volume":"7","author":"H Zhuang","year":"2016","unstructured":"Zhuang H, Yuan X, Chang JY, Song Y, Wang J, Yuan Z, Wang X, Wang P (2016) Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation. Oncotarget 7(30):48842\u201348849. https:\/\/doi.org\/10.18632\/oncotarget.7768","journal-title":"Oncotarget"},{"issue":"6","key":"5121_CR11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3171\/2022.2.Jns212006","volume":"137","author":"SR Dashti","year":"2022","unstructured":"Dashti SR, Kadner RJ, Folley BS, Sheehan JP, Han DY, Kryscio RJ, Carter MB, Shields LBE, Plato BM, Rocca L, Spalding RV, Yao AC, T. L., Fraser JF (2022) Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial. J Neurosurg 137(6):1676\u20131686. https:\/\/doi.org\/10.3171\/2022.2.Jns212006","journal-title":"J Neurosurg"},{"issue":"1","key":"5121_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","volume":"118","author":"B Vellayappan","year":"2024","unstructured":"Vellayappan B, Lim-Fat MJ, Kotecha R, De Salles A, Fariselli L, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan JP, Suh JH, Yomo S, Sahgal A (2024) A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations. Int J Radiat Oncol Biol Phys 118(1):14\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5121_CR19","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.21037\/apm-20-2417","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, He J, Cai L, Lai M, Hu Q, Ren C, Wen L, Wang J, Zhou J, Zhou Z, Li S, Ye M, Shan C, Chen L, Zhou C (2021) Bevacizumab as a treatment for radiation necrosis following stereotactic radiosurgery for brain metastases: clinical and radiation dosimetric impacts. Ann Palliat Med 10(2):2018\u20132026. https:\/\/doi.org\/10.21037\/apm-20-2417","journal-title":"Ann Palliat Med"},{"key":"5121_CR20","doi-asserted-by":"publisher","first-page":"117556","DOI":"10.1016\/j.jns.2021.117556","volume":"427","author":"A Moore","year":"2021","unstructured":"Moore A, Yust-Katz S, Icht O, Eliyahou R, Gordon N, Cohen AY, Goldstein IM, Peled N, Seigal T, Amiel A, Dudnik E (2021) Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. J Neurol Sci 427:117556. https:\/\/doi.org\/10.1016\/j.jns.2021.117556","journal-title":"J Neurol Sci"},{"issue":"1","key":"5121_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-024-12643-6","volume":"24","author":"T Zoto Mustafayev","year":"2024","unstructured":"Zoto Mustafayev T, Turna M, Bolukbasi Y, Tezcanli E, Guney Y, Dincbas FO, Atasoy BM, Ugurluer G, Caglar HB, Atalar B, Ozyar E (2024) Clinical and radiological effects of bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy. BMC Cancer 24(1):918. https:\/\/doi.org\/10.1186\/s12885-024-12643-6","journal-title":"BMC Cancer"},{"key":"5121_CR24","doi-asserted-by":"publisher","first-page":"720506","DOI":"10.3389\/fsurg.2021.720506","volume":"8","author":"Y Weng","year":"2021","unstructured":"Weng Y, Shen J, Zhang L, Fang Z, Xiao F, Zhang C, Fan Z, Huang K, Wang L, Huang B, Wu F, Zhang T, Xu Q (2021) Low-Dosage bevacizumab treatment: effect on radiation necrosis after gamma knife radiosurgery for brain metastases. Front Surg 8:720506. https:\/\/doi.org\/10.3389\/fsurg.2021.720506","journal-title":"Front Surg"},{"issue":"2","key":"5121_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/cas.16053","volume":"115","author":"M Gao","year":"2024","unstructured":"Gao M, Wang X, Wang X, Niu G, Liu X, Zhao S, Wang Y, Yu H, Huo S, Su H, Song Y, Wang X, Zhuang HQ, Yuan ZY (2024) Can low-dose intravenous bevacizumab be as effective as high-dose bevacizumab for cerebral radiation necrosis? Cancer Sci 115(2):589\u2013599. https:\/\/doi.org\/10.1111\/cas.16053","journal-title":"Cancer Sci"},{"issue":"6","key":"5121_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cllc.2024.06.010","volume":"25","author":"D Shibahara","year":"2024","unstructured":"Shibahara D, Tanaka K, Togao O, Shiraishi Y, Yoneshima Y, Iwama E, Yoshitake T, Ishigami K, Okamoto I (2024) Bevacizumab for brain radiation necrosis in patients with nonsquamous nonsmall cell lung Cancer. Clin Lung Cancer 25(6):581\u2013586e583. https:\/\/doi.org\/10.1016\/j.cllc.2024.06.010","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"5121_CR27","doi-asserted-by":"publisher","first-page":"e00454","DOI":"10.1002\/rcr2.454","volume":"7","author":"K Tanigawa","year":"2019","unstructured":"Tanigawa K, Mizuno K, Kamenohara Y, Unoki T, Misono S, Inoue H (2019) Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase-positive lung cancer. Respirol Case Rep 7(7):e00454. https:\/\/doi.org\/10.1002\/rcr2.454","journal-title":"Respirol Case Rep"},{"issue":"6","key":"5121_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/cmr.0000000000000389","volume":"27","author":"IC Glitza","year":"2017","unstructured":"Glitza IC, Guha-Thakurta N, D\u2019Souza NM, Amaria RN, McGovern SL, Rao G, Li J (2017) Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Melanoma Res 27(6):580\u2013584. https:\/\/doi.org\/10.1097\/cmr.0000000000000389","journal-title":"Melanoma Res"},{"issue":"3","key":"5121_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1159\/000357401","volume":"6","author":"M Alessandretti","year":"2013","unstructured":"Alessandretti M, Buzaid AC, Brand\u00e3o R, Brand\u00e3o EP (2013) Low-dose bevacizumab is effective in radiation-induced necrosis. Case Rep Oncol 6(3):598\u2013601. https:\/\/doi.org\/10.1159\/000357401","journal-title":"Case Rep Oncol"},{"issue":"3","key":"5121_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/COC.0b013e31829c3139","volume":"38","author":"NH Sadraei","year":"2015","unstructured":"Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H, Suh JH, Peereboom DM, Stevens GH, Ahluwalia MS (2015) Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience. Am J Clin Oncol 38(3):304\u2013310. https:\/\/doi.org\/10.1097\/COC.0b013e31829c3139","journal-title":"Am J Clin Oncol"},{"key":"5121_CR22","doi-asserted-by":"publisher","first-page":"24364","DOI":"10.1038\/srep24364","volume":"6","author":"H Zhuang","year":"2016","unstructured":"Zhuang H, Yuan X, Zheng Y, Li X, Chang JY, Wang J, Wang X, Yuan Z, Wang P (2016) A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis. Sci Rep 6:24364. https:\/\/doi.org\/10.1038\/srep24364","journal-title":"Sci Rep"},{"issue":"9","key":"5121_CR31","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/neuonc\/not085","volume":"15","author":"D Boothe","year":"2013","unstructured":"Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K (2013) Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol 15(9):1257\u20131263. https:\/\/doi.org\/10.1093\/neuonc\/not085","journal-title":"Neuro Oncol"},{"issue":"3","key":"5121_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/jjco\/hys231","volume":"43","author":"M Furuse","year":"2013","unstructured":"Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T, Kuroiwa T, Miyatake S (2013) Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol 43(3):337\u2013341. https:\/\/doi.org\/10.1093\/jjco\/hys231","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"5121_CR13","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1200\/jco.2010.31.4815","volume":"29","author":"DS Jeyaretna","year":"2011","unstructured":"Jeyaretna DS, Curry WT Jr., Batchelor TT, Stemmer-Rachamimov A, Plotkin SR (2011) Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol 29(7):e159\u2013162. https:\/\/doi.org\/10.1200\/jco.2010.31.4815","journal-title":"J Clin Oncol"},{"issue":"11","key":"5121_CR14","doi-asserted-by":"publisher","first-page":"13265","DOI":"10.18632\/oncotarget.7724","volume":"7","author":"H Zhuang","year":"2016","unstructured":"Zhuang H, Yuan X, Sun D, Bian J, Chang JY, Yuan Z, Wang P (2016) Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report. Oncotarget 7(11):13265\u201313268. https:\/\/doi.org\/10.18632\/oncotarget.7724","journal-title":"Oncotarget"},{"issue":"1","key":"5121_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40644-022-00470-6","volume":"22","author":"A Lasocki","year":"2022","unstructured":"Lasocki A, Sia J, Stuckey SL (2022) Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series. Cancer Imaging 22(1):33. https:\/\/doi.org\/10.1186\/s40644-022-00470-6","journal-title":"Cancer Imaging"},{"issue":"4","key":"5121_CR37","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.adro.2025.101732","volume":"10","author":"CS Dejonckheere","year":"2025","unstructured":"Dejonckheere CS, Scafa D, K\u00e4smann L, Zeyen T, Potthoff A-L, Sch\u00e4fer N, Weller J, Herrlinger U, Schneider M, Vatter H, Grosu A-L, Brehmer S, Giordano FA, Sarria GR, Gkika E, Layer JP (2025) Boswellia serrata for the management of radiation-induced cerebral edema and necrosis: a systematic meta-narrative review of clinical evidence. Adv Radiation Oncol 10(4):101732. https:\/\/doi.org\/10.1016\/j.adro.2025.101732","journal-title":"Adv Radiation Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05121-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T16:30:43Z","timestamp":1755707443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05121-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5121"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05121-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6584649\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}